A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
Article in Clinical Pharmacology & Therapeutics (January 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Clinical Pharmacology & Therapeutics (January 2024)
Article in Scientific Reports (June 2023)
Preprint in bioRxiv (March 2023)